锦欣生殖医疗集团有限公司（01951）于2026年4月9日发布截至2026年3月31日的股份变动月报表。公告显示，公司本月未有新增发行或注销活动，股本结构保持稳定。
根据公告，公司注册股本为5,000,000,000股普通股，每股面值0.00001美元，总额50,000美元，与上月相比无变化。已发行股份（不含库藏股）数目仍为2,744,706,043股，库藏股数目为13,000,000股，合计2,757,706,043股，亦与上月保持一致。
公司另行提及，自2025年12月5日至2026年3月31日期间已回购45,968,000股普通股，惟截至本报告期末尚未注销。期内并无其他关于期权或股权激励计划的新增授出、行使或失效记录。
公司在公告中确认已遵守香港联交所《上市规则》及相关法律规定。该报告由公司首席执行官、代理首席财务官兼执行董事董阳签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.